Bioqual (OTCMKTS:BIOQ) Shares Down 7.1% – Here’s What Happened

Bioqual Inc. (OTCMKTS:BIOQ) shares traded down 7.1% during trading on Thursday . The stock traded as low as $32.50 and last traded at $32.50. 1,272 shares traded hands during mid-day trading, an increase of 782% from the average session volume of 144 shares. The stock had previously closed at $35.00.

Bioqual Price Performance

The firm’s fifty day simple moving average is $35.63 and its 200 day simple moving average is $37.20. The company has a market capitalization of $28.93 million, a price-to-earnings ratio of -30.09 and a beta of -0.21.

Bioqual (OTCMKTS:BIOQ) last announced its earnings results on Tuesday, April 21st. The company reported ($0.84) EPS for the quarter. The firm had revenue of $9.84 million during the quarter. Bioqual had a negative return on equity of 2.69% and a negative net margin of 2.27%.

Bioqual Company Profile

Bioqual, Inc is a U.S.-based contract research organization specializing in preclinical immunology and pharmacology services for the biopharmaceutical industry. The company offers a range of in vivo and in vitro testing solutions designed to support vaccine development, immuno-oncology programs and other therapeutic modalities. Bioqual’s service portfolio encompasses assay development, safety and efficacy studies, biomarker analysis and specialized immunogenicity assessments.

Leveraging proprietary humanized animal models and nonhuman primate research platforms, Bioqual helps clients evaluate biological activity, toxicity and pharmacokinetics of investigational compounds.